Within the entire food ingredients market, there are a relatively  large number of suppliers, due principally to the broad spectrum  of chemistries employed. Segment leadership, global position and  investment in technology are key factors to sustaining profitability. In  addition compared to our business, larger suppliers may often provide  a broader product line and a range of services to food companies  including functional systems or blends. The top suppliers of TSPS  ingredients include FMC, DuPont, J.M. Huber Corporation, Kerry  Group plc and Cargill Incorporated. We also supply alginates, MCC and carrageenan into oral care, cosmetics  and health care markets. Highly refined extracts from selected seaweeds  provide a broad range of alginate functionality, including uses in  antireflux, dental impressions, control release of drugs and wound  dressings. Special grades of carrageenan extracts are used in liquid cough  medicines, toothpaste and a variety of skin care products. Lithium is a highly versatile metal with diverse end-use markets including  both rechargeable and disposable batteries, polymers, pharmaceuticals,  greases/lubricants, glass/ceramics and aluminum production. The markets  for lithium chemicals are global with significant demand growth occurring  outside the U.S. in Japan, China and South Korea. We market a wide  variety of lithium-based products ranging from upstream commodity  lithium carbonate to highly specialized downstream products such  as organolithium compounds and high value materials for batteries. There are only three key producers of lithium: FMC, Rockwood  Holdings, Inc., and Sociedad Química y Minera de Chile S.A., all  of which produce lithium carbonate. FMC and Rockwood are the  primary producers in downstream lithium specialties. Our BioPolymer business sells formulation ingredients to the  pharmaceutical industry. Our raw materials function as binders,  disintegrants, suspending agents, and control release compounds in  the production of both solid and liquid pharmaceutical products. Competitors tend to be grouped by chemistry. Our principal MCC  competitors include J. Rettenmaier & Sôhne GmbH, Ming Tai Chemical  Co., Ltd., Asahi Kasei Corporation and Blanver Farmoquimica Ltda.  While pricing pressure from low cost producers is a common competitive  dynamic, companies like us offset that pressure by providing the most  reliable and broadest range of products and services. Our customers are  pharmaceutical firms who depend upon reliable therapeutic performance  of their drug products. lithium pharmaceutical ingredients Part I  iteM 1 Business overview Our Industrial Chemicals segment, which represents 34 percent of our 2010  consolidated revenues, has low-cost positions in high volume inorganic  chemicals including soda ash and hydrogen peroxide, complemented by  high value, niche positions in specialty alkali and peroxygen products.  Through December 31, 2010, we also held a niche position in phosphorous  chemicals products, however, in November 2010, we made the decision  to exit the phosphate business and have shutdown our Huelva facility  in Spain. Our strategic intent for the Industrial Chemicals Group is to  create a portfolio of high performing businesses exhibiting greater top  and bottom line growth with significantly higher margins and reduced  volatility than in the past. We will achieve this by enhancing our leadership  position in natural soda ash and specialty peroxygens, while restructuring  our Spanish Foret subsidiary to its profitable core. We expect steady  organic growth in our soda ash business due to consistent growth in  global demand. We anticipate significant organic growth in environmental  applications over the next five years, and we see opportunities to expand  our environmental technology platform through targeted acquisitions of  complementary technologies. In addition to solid revenue growth, we  expect improved profit mix stemming from increased specialty market  participation and the benefits of restructuring actions. 8 FMC Corporation    2010 Form 10K industrial Chemicals Financial information (in Millions) industrial CheMiCals: revenue and operatinG MarGin 20062010 1,297 1,027 1,055 1,087 991 Revenue Operating Margin 2006 2007 2008 2009 2010 0% 10% 20% 30% 40% 16% 9% 12% 9% 10% $0 $250 $500 $750 $1,000 $1,250 $1,500 industrial CheMiCals: Capital expenditures and depreCiation  and aMortization 20062010 65 63 69 65 73 68 68 106 71 66 2006 2007 2008 2009 2010 Capital Expenditure Depreciation and Amortization $0 $20 $40 $60 $80 $100 $120